Synergy Pharmaceuticals (SGYP) Rumor Mill Cranks Up Following Allergan CEO Comments
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
On the call, Allergan CEO said the company isn't focused on or looking at large deals. This suggests to some that smaller tuck-in deals would be the top priority (i.e. SGYP-type deals)
Roche and Shire (Nasdaq: SHPG) are also seen as a possible suitors for Synergy.
Shares of SGYP are up 2.2% to $4.66 in early trade.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Twitter (TWTR) Gains on Reports Disney (DIS) Has Rekindled Buyout Interest
- Concho Resources (CXO), PE Investors Seek Buyer for Pipeline System Alpha Crude Connector - DJ
- Stocks with Implied Volatility Movement
Create E-mail Alert Related CategoriesRumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!